Table 3.
CpG | Gene | SNP | SNP Position (hg38 Chr:bp) | Discovery cohort | Replication cohort | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
βINT | PINT | βSS.meQTL | PSS.meQTL | βCTRL.meQTL | PCTRL.meQTL | βINT | PINT | ||||
A. SS-dependent meQTLs | |||||||||||
cg08818207 | TAP1 | rs113547322 | 6:32,238,742 | 0.058 | 1.5 × 10−05 | 0.048 | 0.0004 | NA | > 0.05 | 0.059 | 0.0091 |
cg14392283 | LY6E | rs13273708 | 8:143,002,764 | − 0.018 | 1.6 × 10−04 | − 0.016 | 0.0006 | NA | > 0.05 | − 0.020 | 0.0061 |
cg01309328 | PSMB8 | rs3134951 | 6:32,147,308 | − 0.040 | 4.0 × 10−04 | − 0.024 | 0.0124 | NA | > 0.05 | − 0.040 | 0.0023 |
cg14951497 | STAT1 | rs4853645 | 2:191,839,218 | − 0.029 | 5.5 × 10−04 | − 0.024 | 0.0012 | NA | > 0.05 | − 0.038 | 0.0418 |
cg12906975 | Intergenic (LY6E) | rs55937049 | 8:143,033,566 | − 0.013 | 0.0018 | − 0.011 | 0.0087 | NA | > 0.05 | − 0.017 | 0.0410 |
cg23387863 | SGK269 | rs1079396 | 15:78,137,720 | − 0.024 | 0.0022 | − 0.017 | 0.0119 | NA | > 0.05 | − 0.028 | 0.0141 |
cg10734665 | ATP10A | rs7169481 | 15:25,712,123 | − 0.022 | 0.0031 | 0.018 | 0.0047 | NA | > 0.05 | 0.030 | 0.0138 |
cg08099136 | PSMB8 | rs3129943 | 6:32,370,868 | − 0.030 | 0.0038 | − 0.027 | 0.0050 | NA | > 0.05 | − 0.035 | 0.0108 |
Gene ID | Gene | SNP | SNP Position (hg38 Chr:bp) | Discovery cohort | Replication cohort | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
βINT | PINT | βSS.eQTL | PSS.eQTL | βCTRL.eQTL | PCTRL.eQTL | βINT | PINT | ||||
B.SS-dependent eQTLs | |||||||||||
ENSG00000183486 | MX2 | rs9305702 | 21:40,755,922 | − 0.300 | 1.8 × 10−04 | − 0.302 | 1.8 × 10−04 | NA | > 0.05 | − 0.315 | 0.0172 |
ENSG00000198785 | GRIN3A | rs2417310 | 9:101,964,703 | 0.251 | 4.5 × 10−04 | 0.235 | 7.0 × 10−04 | NA | > 0.05 | 0.262 | 0.0092 |
ENSG00000185885 | IFITM1 | rs12364973 | 11:1,116,140 | 0.386 | 6.9 × 10−04 | 0.280 | 0.0130 | NA | > 0.05 | 0.430 | 0.0476 |
ENSG00000013374 | NUB1 | rs77466830 | 7:151,831,985 | − 0.143 | 7.7 × 10−04 | − 0.151 | 3.5 × 10−04 | NA | > 0.05 | − 0.158 | 0.0345 |
ENSG00000133106 | EPSTI1 | rs9525846 | 13:43,816,621 | − 0.607 | 8.8 × 10−04 | − 0.577 | 2.4 × 10−03 | NA | > 0.05 | − 0.651 | 0.0199 |
ENSG00000188313 | PLSCR1 | rs56077428 | 3:146,981,084 | 0.471 | 0.0010 | 0.357 | 0.0208 | NA | > 0.05 | 0.600 | 0.0185 |
ENSG00000157601 | MX1 | rs9305702 | 21:40,755,922 | − 0.602 | 0.0012 | − 0.496 | 0.0083 | NA | > 0.05 | − 0.779 | 0.0085 |
ENSG00000247317 | LY6E − DT | rs902834 | 8:142,111,410 | 0.167 | 0.0038 | 0.129 | 0.0149 | NA | > 0.05 | 0.149 | 0.0469 |
ENSG00000108691 | CCL2 | rs1490922 | 17:33,725,536 | 0.351 | 0.0044 | 0.307 | 0.0159 | NA | > 0.05 | 0.367 | 0.0252 |
ENSG00000187210 | GCNT1 | rs2377425 | 9:75,947,610 | 0.132 | 0.0047 | 0.083 | 0.0452 | NA | > 0.05 | 0.210 | 0.0068 |
β INT represents the interaction effect between a given SNP and SS status in DNA methylation level.
P INT represents the P-value obtained for the β INT in a linear regression model that adjusts for SNP, SS status, age, sex, batch effects, estimated cell proportions and the first principal genetic component.
β SS.meQTL represents the DNA methylation change with the increased in dosage of the minor allele in SS population for a given SNP.
P SS.meQTL corresponds to the P value from the linear regression model that regresses out the number of minor alleles for a given SNP to DNA methylation levels adjusting by age, sex, batch effects, estimated cell proportions, disease status and first genetic component in SS population.
β CTRL.meQTL represents the DNA methylation change with the increased in dosage of the minor allele in the healthy control population for a given SNP.
P CTRL.meQTL corresponds to the P value from the linear regression model that regresses out the number of minor alleles for a given SNP to DNA methylation levels adjusting by age, sex, batch effects, estimated cell proportions, disease status and first genetic component in the healthy control population.
NA represents effects that are non significant (P > 0.05).